1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anosmia Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Therapies 1.2.3 Medications 1.3 Market by Application 1.3.1 Global Anosmia Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Idiopathic Anosmia 1.3.3 Congenital Anosmia 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anosmia Market Perspective (2017-2028) 2.2 Anosmia Growth Trends by Region 2.2.1 Anosmia Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Anosmia Historic Market Size by Region (2017-2022) 2.2.3 Anosmia Forecasted Market Size by Region (2023-2028) 2.3 Anosmia Market Dynamics 2.3.1 Anosmia Industry Trends 2.3.2 Anosmia Market Drivers 2.3.3 Anosmia Market Challenges 2.3.4 Anosmia Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anosmia Players by Revenue 3.1.1 Global Top Anosmia Players by Revenue (2017-2022) 3.1.2 Global Anosmia Revenue Market Share by Players (2017-2022) 3.2 Global Anosmia Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Anosmia Revenue 3.4 Global Anosmia Market Concentration Ratio 3.4.1 Global Anosmia Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anosmia Revenue in 2021 3.5 Anosmia Key Players Head office and Area Served 3.6 Key Players Anosmia Product Solution and Service 3.7 Date of Enter into Anosmia Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anosmia Breakdown Data by Type 4.1 Global Anosmia Historic Market Size by Type (2017-2022) 4.2 Global Anosmia Forecasted Market Size by Type (2023-2028) 5 Anosmia Breakdown Data by Application 5.1 Global Anosmia Historic Market Size by Application (2017-2022) 5.2 Global Anosmia Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Anosmia Market Size (2017-2028) 6.2 North America Anosmia Market Size by Type 6.2.1 North America Anosmia Market Size by Type (2017-2022) 6.2.2 North America Anosmia Market Size by Type (2023-2028) 6.2.3 North America Anosmia Market Share by Type (2017-2028) 6.3 North America Anosmia Market Size by Application 6.3.1 North America Anosmia Market Size by Application (2017-2022) 6.3.2 North America Anosmia Market Size by Application (2023-2028) 6.3.3 North America Anosmia Market Share by Application (2017-2028) 6.4 North America Anosmia Market Size by Country 6.4.1 North America Anosmia Market Size by Country (2017-2022) 6.4.2 North America Anosmia Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Anosmia Market Size (2017-2028) 7.2 Europe Anosmia Market Size by Type 7.2.1 Europe Anosmia Market Size by Type (2017-2022) 7.2.2 Europe Anosmia Market Size by Type (2023-2028) 7.2.3 Europe Anosmia Market Share by Type (2017-2028) 7.3 Europe Anosmia Market Size by Application 7.3.1 Europe Anosmia Market Size by Application (2017-2022) 7.3.2 Europe Anosmia Market Size by Application (2023-2028) 7.3.3 Europe Anosmia Market Share by Application (2017-2028) 7.4 Europe Anosmia Market Size by Country 7.4.1 Europe Anosmia Market Size by Country (2017-2022) 7.4.2 Europe Anosmia Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Anosmia Market Size (2017-2028) 8.2 Asia-Pacific Anosmia Market Size by Type 8.2.1 Asia-Pacific Anosmia Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Anosmia Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Anosmia Market Share by Type (2017-2028) 8.3 Asia-Pacific Anosmia Market Size by Application 8.3.1 Asia-Pacific Anosmia Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Anosmia Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Anosmia Market Share by Application (2017-2028) 8.4 Asia-Pacific Anosmia Market Size by Region 8.4.1 Asia-Pacific Anosmia Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Anosmia Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anosmia Market Size (2017-2028) 9.2 Latin America Anosmia Market Size by Type 9.2.1 Latin America Anosmia Market Size by Type (2017-2022) 9.2.2 Latin America Anosmia Market Size by Type (2023-2028) 9.2.3 Latin America Anosmia Market Share by Type (2017-2028) 9.3 Latin America Anosmia Market Size by Application 9.3.1 Latin America Anosmia Market Size by Application (2017-2022) 9.3.2 Latin America Anosmia Market Size by Application (2023-2028) 9.3.3 Latin America Anosmia Market Share by Application (2017-2028) 9.4 Latin America Anosmia Market Size by Country 9.4.1 Latin America Anosmia Market Size by Country (2017-2022) 9.4.2 Latin America Anosmia Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anosmia Market Size (2017-2028) 10.2 Middle East & Africa Anosmia Market Size by Type 10.2.1 Middle East & Africa Anosmia Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Anosmia Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Anosmia Market Share by Type (2017-2028) 10.3 Middle East & Africa Anosmia Market Size by Application 10.3.1 Middle East & Africa Anosmia Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Anosmia Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Anosmia Market Share by Application (2017-2028) 10.4 Middle East & Africa Anosmia Market Size by Country 10.4.1 Middle East & Africa Anosmia Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Anosmia Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Mylan N.V 11.1.1 Mylan N.V Company Details 11.1.2 Mylan N.V Business Overview 11.1.3 Mylan N.V Anosmia Introduction 11.1.4 Mylan N.V Revenue in Anosmia Business (2017-2022) 11.1.5 Mylan N.V Recent Developments 11.2 Pfizer Inc 11.2.1 Pfizer Inc Company Details 11.2.2 Pfizer Inc Business Overview 11.2.3 Pfizer Inc Anosmia Introduction 11.2.4 Pfizer Inc Revenue in Anosmia Business (2017-2022) 11.2.5 Pfizer Inc Recent Developments 11.3 Atom Pharma 11.3.1 Atom Pharma Company Details 11.3.2 Atom Pharma Business Overview 11.3.3 Atom Pharma Anosmia Introduction 11.3.4 Atom Pharma Revenue in Anosmia Business (2017-2022) 11.3.5 Atom Pharma Recent Developments 11.4 RANBAXY LABORATORIES LIMITED 11.4.1 RANBAXY LABORATORIES LIMITED Company Details 11.4.2 RANBAXY LABORATORIES LIMITED Business Overview 11.4.3 RANBAXY LABORATORIES LIMITED Anosmia Introduction 11.4.4 RANBAXY LABORATORIES LIMITED Revenue in Anosmia Business (2017-2022) 11.4.5 RANBAXY LABORATORIES LIMITED Recent Developments 11.5 Alde Medi Impex 11.5.1 Alde Medi Impex Company Details 11.5.2 Alde Medi Impex Business Overview 11.5.3 Alde Medi Impex Anosmia Introduction 11.5.4 Alde Medi Impex Revenue in Anosmia Business (2017-2022) 11.5.5 Alde Medi Impex Recent Developments 11.6 GlaxoSmithkline Plc 11.6.1 GlaxoSmithkline Plc Company Details 11.6.2 GlaxoSmithkline Plc Business Overview 11.6.3 GlaxoSmithkline Plc Anosmia Introduction 11.6.4 GlaxoSmithkline Plc Revenue in Anosmia Business (2017-2022) 11.6.5 GlaxoSmithkline Plc Recent Developments 11.7 Sandoz (Novasrtis AG) 11.7.1 Sandoz (Novasrtis AG) Company Details 11.7.2 Sandoz (Novasrtis AG) Business Overview 11.7.3 Sandoz (Novasrtis AG) Anosmia Introduction 11.7.4 Sandoz (Novasrtis AG) Revenue in Anosmia Business (2017-2022) 11.7.5 Sandoz (Novasrtis AG) Recent Developments 11.8 Inke S.A. 11.8.1 Inke S.A. Company Details 11.8.2 Inke S.A. Business Overview 11.8.3 Inke S.A. Anosmia Introduction 11.8.4 Inke S.A. Revenue in Anosmia Business (2017-2022) 11.8.5 Inke S.A. Recent Developments 11.9 Taj Pharmaceuticals Limited 11.9.1 Taj Pharmaceuticals Limited Company Details 11.9.2 Taj Pharmaceuticals Limited Business Overview 11.9.3 Taj Pharmaceuticals Limited Anosmia Introduction 11.9.4 Taj Pharmaceuticals Limited Revenue in Anosmia Business (2017-2022) 11.9.5 Taj Pharmaceuticals Limited Recent Developments 11.10 Sanofi 11.10.1 Sanofi Company Details 11.10.2 Sanofi Business Overview 11.10.3 Sanofi Anosmia Introduction 11.10.4 Sanofi Revenue in Anosmia Business (2017-2022) 11.10.5 Sanofi Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Anosmia Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Therapies Table 3. Key Players of Medications Table 4. Global Anosmia Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Anosmia Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Anosmia Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Anosmia Market Share by Region (2017-2022) Table 8. Global Anosmia Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Anosmia Market Share by Region (2023-2028) Table 10. Anosmia Market Trends Table 11. Anosmia Market Drivers Table 12. Anosmia Market Challenges Table 13. Anosmia Market Restraints Table 14. Global Anosmia Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Anosmia Revenue Share by Players (2017-2022) Table 16. Global Top Anosmia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anosmia as of 2021) Table 17. Ranking of Global Top Anosmia Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Anosmia Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Anosmia Product Solution and Service Table 21. Date of Enter into Anosmia Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Anosmia Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Anosmia Revenue Market Share by Type (2017-2022) Table 25. Global Anosmia Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Anosmia Revenue Market Share by Type (2023-2028) Table 27. Global Anosmia Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Anosmia Revenue Share by Application (2017-2022) Table 29. Global Anosmia Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Anosmia Revenue Share by Application (2023-2028) Table 31. North America Anosmia Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Anosmia Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Anosmia Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Anosmia Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Anosmia Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Anosmia Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Anosmia Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Anosmia Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Anosmia Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Anosmia Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Anosmia Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Anosmia Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Anosmia Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Anosmia Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Anosmia Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Anosmia Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Anosmia Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Anosmia Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Anosmia Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Anosmia Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Anosmia Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Anosmia Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Anosmia Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Anosmia Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Anosmia Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Anosmia Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Anosmia Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Anosmia Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Anosmia Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Anosmia Market Size by Country (2023-2028) & (US$ Million) Table 61. Mylan N.V Company Details Table 62. Mylan N.V Business Overview Table 63. Mylan N.V Anosmia Product Table 64. Mylan N.V Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 65. Mylan N.V Recent Developments Table 66. Pfizer Inc Company Details Table 67. Pfizer Inc Business Overview Table 68. Pfizer Inc Anosmia Product Table 69. Pfizer Inc Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 70. Pfizer Inc Recent Developments Table 71. Atom Pharma Company Details Table 72. Atom Pharma Business Overview Table 73. Atom Pharma Anosmia Product Table 74. Atom Pharma Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 75. Atom Pharma Recent Developments Table 76. RANBAXY LABORATORIES LIMITED Company Details Table 77. RANBAXY LABORATORIES LIMITED Business Overview Table 78. RANBAXY LABORATORIES LIMITED Anosmia Product Table 79. RANBAXY LABORATORIES LIMITED Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 80. RANBAXY LABORATORIES LIMITED Recent Developments Table 81. Alde Medi Impex Company Details Table 82. Alde Medi Impex Business Overview Table 83. Alde Medi Impex Anosmia Product Table 84. Alde Medi Impex Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 85. Alde Medi Impex Recent Developments Table 86. GlaxoSmithkline Plc Company Details Table 87. GlaxoSmithkline Plc Business Overview Table 88. GlaxoSmithkline Plc Anosmia Product Table 89. GlaxoSmithkline Plc Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 90. GlaxoSmithkline Plc Recent Developments Table 91. Sandoz (Novasrtis AG) Company Details Table 92. Sandoz (Novasrtis AG) Business Overview Table 93. Sandoz (Novasrtis AG) Anosmia Product Table 94. Sandoz (Novasrtis AG) Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 95. Sandoz (Novasrtis AG) Recent Developments Table 96. Inke S.A. Company Details Table 97. Inke S.A. Business Overview Table 98. Inke S.A. Anosmia Product Table 99. Inke S.A. Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 100. Inke S.A. Recent Developments Table 101. Taj Pharmaceuticals Limited Company Details Table 102. Taj Pharmaceuticals Limited Business Overview Table 103. Taj Pharmaceuticals Limited Anosmia Product Table 104. Taj Pharmaceuticals Limited Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 105. Taj Pharmaceuticals Limited Recent Developments Table 106. Sanofi Company Details Table 107. Sanofi Business Overview Table 108. Sanofi Anosmia Product Table 109. Sanofi Revenue in Anosmia Business (2017-2022) & (US$ Million) Table 110. Sanofi Recent Developments Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Anosmia Market Share by Type: 2021 VS 2028 Figure 2. Therapies Features Figure 3. Medications Features Figure 4. Global Anosmia Market Share by Application: 2021 VS 2028 Figure 5. Idiopathic Anosmia Case Studies Figure 6. Congenital Anosmia Case Studies Figure 7. Anosmia Report Years Considered Figure 8. Global Anosmia Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Anosmia Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Anosmia Market Share by Region: 2021 VS 2028 Figure 11. Global Anosmia Market Share by Players in 2021 Figure 12. Global Top Anosmia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anosmia as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Anosmia Revenue in 2021 Figure 14. North America Anosmia Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Anosmia Market Size Market Share by Type (2017-2028) Figure 16. North America Anosmia Market Size Market Share by Application (2017-2028) Figure 17. North America Anosmia Market Size Share by Country (2017-2028) Figure 18. United States Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Anosmia Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Anosmia Market Size Market Share by Type (2017-2028) Figure 22. Europe Anosmia Market Size Market Share by Application (2017-2028) Figure 23. Europe Anosmia Market Size Share by Country (2017-2028) Figure 24. Germany Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Anosmia Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Anosmia Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Anosmia Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Anosmia Market Size Share by Region (2017-2028) Figure 34. China Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America Anosmia Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Anosmia Market Size Market Share by Type (2017-2028) Figure 42. Latin America Anosmia Market Size Market Share by Application (2017-2028) Figure 43. Latin America Anosmia Market Size Share by Country (2017-2028) Figure 44. Mexico Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Anosmia Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Anosmia Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Anosmia Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Anosmia Market Size Share by Country (2017-2028) Figure 50. Turkey Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Anosmia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Mylan N.V Revenue Growth Rate in Anosmia Business (2017-2022) Figure 54. Pfizer Inc Revenue Growth Rate in Anosmia Business (2017-2022) Figure 55. Atom Pharma Revenue Growth Rate in Anosmia Business (2017-2022) Figure 56. RANBAXY LABORATORIES LIMITED Revenue Growth Rate in Anosmia Business (2017-2022) Figure 57. Alde Medi Impex Revenue Growth Rate in Anosmia Business (2017-2022) Figure 58. GlaxoSmithkline Plc Revenue Growth Rate in Anosmia Business (2017-2022) Figure 59. Sandoz (Novasrtis AG) Revenue Growth Rate in Anosmia Business (2017-2022) Figure 60. Inke S.A. Revenue Growth Rate in Anosmia Business (2017-2022) Figure 61. Taj Pharmaceuticals Limited Revenue Growth Rate in Anosmia Business (2017-2022) Figure 62. Sanofi Revenue Growth Rate in Anosmia Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Mylan N.V Pfizer Inc Atom Pharma RANBAXY LABORATORIES LIMITED Alde Medi Impex GlaxoSmithkline Plc Sandoz (Novasrtis AG) Inke S.A. Taj Pharmaceuticals Limited Sanofi